Clinical trial
Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00027807 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00027807 |
|---|---|
| Title | Biological Therapy in Treating Women With Stage IV Breast Cancer |
| Official title | Treatment of Stage IV Breast Cancer With OKT3 x Herceptin Armed Activated T Cells, Low Dose IL-2, And GM-CSF (Phase I Only as of 4-22-09 as Per IRB Approval Date) |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological |
| Interventions | Aldesleukin, Sargramostim, therapeutic autologous lymphocytes |
| Enrollment | 6 |
| Start date | Oct 1, 2001 |
| Primary completion | Sep 1, 2010 |
| Completion | Mar 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: